Clinical-stage biotechnology company Vaxxas has appointed three global vaccine experts as advisors as it progresses its ...

Foreign aid programs at risk of being cut by Trump and Musk represent a tiny fraction of overall federal spending.

Pfizer reported strong 2024 profits Wednesday on the same day the Connecticut Attorney General’s office released a statement ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...

Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...

Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team as the company ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 8 includes Lara Exploration, Imperial Oil, Avino ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Container shipping liner Hapag-Lloyd will be able to cope with the advent of U.S. tariffs on Chinese products, its chief executive told reporters on Tuesday. Ciara Lee reports.

Bose, 54, promised a junior colleague more money for a 'couple of hours' work than he would make in a month if she went along ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...